English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT

Released

Journal Article

Mesenchymal stromal cells improve transplanted islet survival and islet function in a syngeneic mouse model.

MPS-Authors
/persons/resource/persons219024

Borg,  Danielle
Max Planck Institute of Molecular Cell Biology and Genetics, Max Planck Society;

/persons/resource/persons219009

Bickle,  Marc
Max Planck Institute of Molecular Cell Biology and Genetics, Max Planck Society;

Speier,  Stephan
Max Planck Society;

/persons/resource/persons219023

Bonifacio,  Enzio
Max Planck Institute of Molecular Cell Biology and Genetics, Max Planck Society;

Hommel,  Angela
Max Planck Society;

External Resource
No external resources are shared
Fulltext (restricted access)
There are currently no full texts shared for your IP range.
Fulltext (public)
There are no public fulltexts stored in PuRe
Supplementary Material (public)
There is no public supplementary material available
Citation

Borg, D., Weigelt, M., Wilhelm, C., Gerlach, M., Bickle, M., Speier, S., et al. (2014). Mesenchymal stromal cells improve transplanted islet survival and islet function in a syngeneic mouse model. Diabetologia, 57(3), 522-531.


Cite as: https://hdl.handle.net/21.11116/0000-0001-05B3-F
Abstract
Islet transplantation is used therapeutically in a minority of patients with type 1 diabetes. Successful outcomes are hampered by early islet beta cell loss. The adjuvant co-transplantation of mesenchymal stromal cells (MSCs) has the promise to improve islet transplant outcome.